Use of continuous glucose monitors in low- and middle-income countries: A scoping review

被引:8
作者
Bernabe-Ortiz, Antonio [1 ,2 ]
Carrillo-Larco, Rodrigo M. [3 ,4 ]
Safary, Elvis [5 ]
Vetter, Beatrice [5 ]
Lazo-Porras, Maria [1 ,6 ,7 ]
机构
[1] Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru
[2] Univ Cient Sur, Lima, Peru
[3] Emory Univ, Emory Global Diabet Res Ctr, Atlanta, GA USA
[4] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA USA
[5] FIND, Geneva, Switzerland
[6] Univ Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland
[7] Geneva Univ Hosp, Geneva, Switzerland
关键词
diabetes; glycaemic control; health technologies; scoping review; INSULIN PUMP THERAPY; GLYCEMIC CONTROL; DIABETES-MELLITUS; TYPE-1; OUTCOMES; SYSTEM; LIFE;
D O I
10.1111/dme.15089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The use of continuous glucose monitors (CGMs) has been shown to have positive impact on diabetes management for people with type 1 diabetes (T1DM), type 2 diabetes (T2DM) and gestational diabetes (GDM) in high-income countries. However, as useful as CGMs are, the experience in low-and middle-income countries (LMICs) is limited and has not been summarized.Methods: A scoping review of the scientific literature was conducted. Medline, Embase, Global Health and Scopus were used to seek original research conducted in LMICs. The search results were screened by two reviewers independently. We included studies assessing health outcomes following the use of CGMs at the individual level (e.g. glycaemic control or complications) and at the health system level (e.g. barriers, facilitators and cost-effectiveness) in English, Portuguese, Spanish and French.Results were summarized narratively. Results: From 4772 records found in database search, 27 reports were included; most of them from China (n = 7), Colombia (n = 5) and India (n = 4). Thirteen reports studied T1DM, five T2DM, seven both T1DM and T2DM and two GDM. Seven reports presented results of experimental studies (five randomized trials and two quasi-experimental); two on cost-effective analysis and the remaining 18 were observational. Studies showed that CGMs improved surrogate glycaemic outcomes (HbA1c reduction), hard endpoints (lower hospitalization rates and diabetes complications) and patient-oriented outcomes (quality of life). However, several caveats were identified: mostly observational studies, few participants in trials, short follow -up and focused on surrogate outcomes.Conclusions: The scoping review identified that studies about CGMs in LMICs have several limitations. Stronger study designs, appropriate sample sizes and the inclusion of patient-important outcomes should be considered to inform the evidence about CGMs for the management of people with diabetes in LMICs.
引用
收藏
页数:10
相关论文
共 44 条
[1]   9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S125-S143
[2]   7. Diabetes Technology: Standards of Medical Care in Diabetes-2022 [J].
不详 .
DIABETES CARE, 2022, 45 :S97-S112
[3]   A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes [J].
Anjana, Ranjit Mohan ;
Kesavadev, Jothydev ;
Neeta, Deshpande ;
Tiwaskar, Mangesh ;
Pradeepa, Rajendra ;
Jebarani, Saravanan ;
Thangamani, Suresh ;
Sastry, Nadiminty Ganapathi ;
Kumar, Srivastava Brijendra ;
Ramu, Muthu ;
Gupta, Pokal Prasanna Kumar ;
Vignesh, Jayaprakash ;
Chandru, Sundramoorthy ;
Kayalvizhi, Sengottuvel ;
Jagdish, Padoor Sethuraman ;
Uthra, Subash Chandra Bose ;
Lovelena, Munawar ;
Jyoti, Sah ;
Priya, Sengodan Suguna ;
Kannan, Alagarsamy ;
Mohan, Viswanathan ;
Unnikrishnan, Ranjit .
DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (09) :533-540
[4]   Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes [J].
Bergenstal, Richard M. ;
Kerr, Matthew S. D. ;
Roberts, Gregory J. ;
Souto, Diana ;
Nabutovsky, Yelena ;
Hirsch, Irl B. .
JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (04)
[5]   Risk factors for incident cardiovascular events among adults in low- and middle-income countries: A systematic review and meta-analysis of prospective cohort studies [J].
Birhanu, Mulugeta Molla ;
Bin Zaman, Sojib ;
Thrift, Amanda G. ;
Evans, Roger G. ;
Zengin, Ayse .
PREVENTIVE MEDICINE, 2022, 158
[6]   The effects of three months long continuous glucose monitoring in children with type 1 diabetes on multiple daily insulin injections [J].
Bukara-Radujkovic, Gordana ;
Miljkovic, Vesna ;
Lakic, Sinisa .
VOJNOSANITETSKI PREGLED, 2018, 75 (12) :1209-1215
[7]   'I don't sleep through the night': Qualitative study of sleep in type 1 diabetes [J].
Carreon, Samantha A. ;
Cao, Viena T. ;
Anderson, Barbara J. ;
Thompson, Deborah, I ;
Marrero, David G. ;
Hilliard, Marisa E. .
DIABETIC MEDICINE, 2022, 39 (05)
[8]   Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study [J].
Charleer, Sara ;
Mathieu, Chantal ;
Nobels, Frank ;
De Block, Christophe ;
Radermecker, Regis P. ;
Hermans, Michel P. ;
Taes, Youri ;
Vercammen, Chris ;
T'Sjoen, Guy ;
Crenier, Laurent ;
Fieuws, Steffen ;
Keymeulen, Bart ;
Gillard, Pieter .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (03) :1224-1232
[9]   Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019 [J].
Deng, Yujiao ;
Li, Na ;
Wu, Ying ;
Wang, Meng ;
Yang, Si ;
Zheng, Yi ;
Deng, Xinyue ;
Xiang, Dong ;
Zhu, Yuyao ;
Xu, Peng ;
Zhai, Zhen ;
Zhang, Dai ;
Dai, Zhijun ;
Gao, Jie .
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[10]  
Eren E., 2017, Guncel Pediatri: Journal of Current Pediatrics, V15, P38